First, we studied the expression of EMT markers vimentin, fibronectin, N-cadherin and E-cadherin in a set of 23 radical prostatectomy (RP) specimens to determine which marker is most representative for EMT in clinical specimens and whether EMT markers were co-expressed within the same tumor areas. This evidence concerns the gene FN1 and neoplasm.